|
References (continued)
6. Power R, Tate HL, McGill
SM, Taylor C. A Qualitative Study Of The Psychosocial Implications Of Lipodystrophy
Syndrome On HIV Positive Individuals. Sex
Transm Infect 2003;79(2):137-41.
7. Galli M, Ridolfo AL,
Gervasoni C, Vaccarezza M, et al. Lipoprotein Metabolism Under HAART. Presentation
at the 1st European Symposium, Clinical Significance of Lipoprotein Disorders
in HIV-Positive Patients, Munich, 22 Nov 2003. Eur
J Med Res 2003;8(Suppl Ii):9-10; abstracts
in full; and results
of the Icona study in Italian.
8. Collazos J, Rodriguez-Guardado
A, Maradona JA, Mayo J, et al. Factors Influencing The Development Of Lipodystrophy
In Human Immunodeficiency Virus-Infected Patients. Scand
J Infect Dis 2003;35(5):339-40.
9. Vigano A, Mora S, Brambilla
P, Schneider L, et al. Impaired Growth Hormone Secretion Correlates With
Visceral Adiposity In Highly Active Antiretroviral Treated HIV-Infected
Adolescents. AIDS
2003;17(10):1435-41.
10. Kosmiski L, Kuritzkes
D, Hamilton J, Sharp T, et a1. Fat Distribution Is Altered In HIV-Infected
Men Without Clinical Evidence Of The HIV Lipodystrophy Syndrome. HIV
Medicine 2003;4(3):235.
11. Miller J, Carr A,
Emery1 S, Law M, et al. HIV Lipodystrophy: Prevalence, Severity And Correlates
Of Risk In Australia. HIV
Medicine 2003;4(3):293.
|
|